Gil Ben-Menachem
Keine laufenden Positionen mehr
Karriereverlauf von Gil Ben-Menachem
Ehemalige bekannte Positionen von Gil Ben-Menachem
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Präsident | 01.01.2013 | 25.02.2013 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - | - |
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Corporate Officer/Principal | - | - |
| PURPLE BIOTECH LTD | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | 08.01.2016 | - |
Ausbildung von Gil Ben-Menachem
| University of Maryland | Masters Business Admin |
| The Hebrew University of Jerusalem | Doctorate Degree |
Statistik
International
| Israel | 6 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| President | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| PURPLE BIOTECH LTD | Health Technology |
| Private Unternehmen | 2 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
- Börse
- Insiders
- Gil Ben-Menachem
- Erfahrung